Pneumonectomy for non-Small cell lung cancer: predictors of operative morality and survival

Citation
C. Alexiou et al., Pneumonectomy for non-Small cell lung cancer: predictors of operative morality and survival, EUR J CAR-T, 20(3), 2001, pp. 476-480
Citations number
25
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
ISSN journal
10107940 → ACNP
Volume
20
Issue
3
Year of publication
2001
Pages
476 - 480
Database
ISI
SICI code
1010-7940(200109)20:3<476:PFNCLC>2.0.ZU;2-M
Abstract
Objective: The purpose of this study was to identify predictors of operativ e mortality and survival following pneumonectomy for nonsmall cell lung can cer (NSCLC). Methods: All 206 patients having a pneumonectomy for NSCLC bet ween 1991 and 1997 in our unit were prospectively studied. There were 162 m ales (79%) and 44 females (21%) with a mean age (+/- standard deviation) of 61 +/- 7.7 years (range 34-81 years). Squamous cell (75%) and adenocarcino ma (17.0%) were the predominant histological types. The possible impact of 29 parameters on operative mortality and survival was tested with univariat e and multivariate analysis. The mean follow-up was 2.3 +/- 1.2 years, rang ing between 0 and 6.8 years, and it was complete. Results: Operative mortal ity was 6.8% (14 deaths). On multiple logistic regression older age (P = 0. 04) and the development post-operatively of bronchopleural fistula (BPF) (P = 0.01) were independent predictors of operative mortality. The overall, K aplan-Meier, 1-, 3- and 5-year survival (+/- standard error from the mean), inclusive of operative mortality, was 68 +/- 3.3, 42 +/- 4.1 and 35 +/- 4. 5%. On Cox proportional hazards regression adenocarcinoma (P = 0.006), the development of BPF (P = 0.003), older age (P = 0.03) and higher pathologica l stage (P = 0.02) were independent adverse predictors of survival. Conclus ion: Pneumonectomy for NSCLC carries a considerable, but acceptable, operat ive mortality and provides an important survival benefit. This study sugges ts that older age and BPF are major determinants of an unfavourable in-hosp ital outcome; older age, BPF, adenocarcinoma cell type and higher pathologi cal stage significantly reduce the probability of a long-term survival. (C) 2001 Elsevier Science B.V. All rights reserved.